This document is a printout of page 3 of 4 of an LA Times interview with Alan Trounson, dated May 29, 2013. Trounson discusses stem cell research, public perception, funding returns compared to the Human Genome Project, and conflict of interest issues at the California Institute for Regenerative Medicine (CIRM). The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production for a congressional investigation.
Page 2 of 4 of an LA Times interview with Alan Trounson (dated May 29, 2013) discussing the state of stem cell research in California. Trounson outlines plans to request $70 million from the CIRM board to establish a network of clinics and compares California's collaborative research environment (funded by Proposition 71's $3 billion) to the competitive environments of Harvard and Australia. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a congressional document production.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity